RA Capital Management - BOLT BIOTHERAPEUTICS INC ownership

BOLT BIOTHERAPEUTICS INC's ticker is BOLT and the CUSIP is 097702104. A total of 63 filers reported holding BOLT BIOTHERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
RA Capital Management ownership history of BOLT BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2022$789,000
-14.1%
533,432
+18.5%
0.02%
-29.2%
Q2 2022$918,000
-92.1%
450,141
-81.1%
0.02%
-88.3%
Q4 2021$11,654,000
-61.3%
2,378,3250.0%0.20%
-50.8%
Q3 2021$30,086,000
-18.2%
2,378,3250.0%0.42%
-29.3%
Q2 2021$36,769,000
-53.0%
2,378,3250.0%0.59%
-50.0%
Q1 2021$78,271,0002,378,3251.18%
Other shareholders
BOLT BIOTHERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Pivotal bioVenture Partners Investment Advisor LLC 1,891,467$29,242,00011.52%
Nan Fung Group Holdings Ltd 1,166,952$18,041,0005.60%
Novo Holdings A/S 4,503,991$69,632,0003.09%
Vivo Capital, LLC 3,871,291$59,850,0002.59%
Sofinnova Investments, Inc. 2,754,437$42,584,0002.45%
Ally Bridge Group (NY) LLC 412,267$6,374,0001.58%
Samsara BioCapital, LLC 737,459$11,401,0001.41%
Board of Trustees of The Leland Stanford Junior University 719,546$11,125,0001.04%
RA Capital Management 2,378,325$36,769,0000.59%
Rock Springs Capital Management LP 1,619,248$25,034,0000.50%
View complete list of BOLT BIOTHERAPEUTICS INC shareholders